{"id":"https://openalex.org/W2000279511","doi":"https://doi.org/10.1002/(sici)1096-911x(200004)34:4<237::aid-mpo1>3.0.co;2-j","title":"Metaiodobenzylguanidine assessment of metastatic neuroblastoma: Observer dependency and chemosensitivity evaluation","display_name":"Metaiodobenzylguanidine assessment of metastatic neuroblastoma: Observer dependency and chemosensitivity evaluation","alternate_titles":[],"publication_year":2000,"publication_date":"2000-04-01","ids":{"openalex":"https://openalex.org/W2000279511","doi":"https://doi.org/10.1002/(sici)1096-911x(200004)34:4<237::aid-mpo1>3.0.co;2-j","mag":"2000279511","pmid":"https://pubmed.ncbi.nlm.nih.gov/10742058"},"language":"en","primary_location":{"id":"doi:10.1002/(sici)1096-911x(200004)34:4<237::aid-mpo1>3.0.co;2-j","doi":"https://doi.org/10.1002/(sici)1096-911x(200004)34:4<237::aid-mpo1>3.0.co;2-j","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1096-911x(200004)34:4<237::aid-mpo1>3.0.co;2-j","pdf_url":null,"source":{"id":"https://openalex.org/S179546387","display_name":"Medical and Pediatric Oncology","issn_l":"0098-1532","issn":["0098-1532","1096-911X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320571","host_organization_name":"Alan R. Liss, Inc.","host_organization_lineage":["https://openalex.org/P4310320571"],"host_organization_lineage_names":["Alan R. Liss, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical and Pediatric Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000279511"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033870647","display_name":"Didier Frappaz","orcid":"https://orcid.org/0000-0002-3684-9909","observed_orcids":["https://orcid.org/0000-0002-3684-9909"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"D. Frappaz","raw_affiliation_strings":["D\u00e9partement de P\u00e9datrie, M\u00e9decine Nucl\u00e9aire and Biostatistiques, Centre L\u00e9on B\u00e9rard, Lyon, France. frappaz@lyon.fnclcc.fr","D\u00e9partement de P\u00e9datrie, M\u00e9decine Nucl\u00e9aire and Biostatistiques, Centre L\u00e9on B\u00e9rard, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de P\u00e9datrie, M\u00e9decine Nucl\u00e9aire and Biostatistiques, Centre L\u00e9on B\u00e9rard, Lyon, France. frappaz@lyon.fnclcc.fr","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"D\u00e9partement de P\u00e9datrie, M\u00e9decine Nucl\u00e9aire and Biostatistiques, Centre L\u00e9on B\u00e9rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074342733","display_name":"A. Bonneu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Bonneu","raw_affiliation_strings":["De\u0301partement de Me\u0301decine Nucle\u0301aire, Centre Cl. Regaud, Toulouse, France","D\u00e9partement de M\u00e9decine Nucl\u00e9aire, Centre Cl. Regaud, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"De\u0301partement de Me\u0301decine Nucle\u0301aire, Centre Cl. Regaud, Toulouse, France","institution_ids":["https://openalex.org/I4210128666"]},{"raw_affiliation_string":"D\u00e9partement de M\u00e9decine Nucl\u00e9aire, Centre Cl. Regaud, Toulouse, France","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066048798","display_name":"P. Chauvot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Chauvot","raw_affiliation_strings":["De\u0301partement de Pe\u0301datrie, Me\u0301decine Nucle\u0301aire and Biostatistiques, Centre Le\u0301on Be\u0301rard, Lyon, France","D\u00e9partement de P\u00e9datrie, M\u00e9decine Nucl\u00e9aire and Biostatistiques, Centre L\u00e9on B\u00e9rard, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"De\u0301partement de Pe\u0301datrie, Me\u0301decine Nucle\u0301aire and Biostatistiques, Centre Le\u0301on Be\u0301rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"D\u00e9partement de P\u00e9datrie, M\u00e9decine Nucl\u00e9aire and Biostatistiques, Centre L\u00e9on B\u00e9rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006972800","display_name":"V\u00e9ronique Edeline","orcid":"https://orcid.org/0000-0002-2720-9803","observed_orcids":["https://orcid.org/0000-0002-2720-9803"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. Edeline","raw_affiliation_strings":["De\u0301partement de Me\u0301decine Nucle\u0301aire, Institut Curie, Paris, France","D\u00e9partement de m\u00e9decine nucl\u00e9aire, institut Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"De\u0301partement de Me\u0301decine Nucle\u0301aire, Institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"D\u00e9partement de m\u00e9decine nucl\u00e9aire, institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010629629","display_name":"Francesco Giammarile","orcid":"https://orcid.org/0000-0002-0550-7893","observed_orcids":["https://orcid.org/0000-0002-0550-7893"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Giammarile","raw_affiliation_strings":["De\u0301partement de Me\u0301decine Nucle\u0301aire, Institut Gustave Roussy, Villejuif, France","D\u00e9partement de M\u00e9decine Nucl\u00e9aire, Institut Gustave-Roussy, Villejuif France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"De\u0301partement de Me\u0301decine Nucle\u0301aire, Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"D\u00e9partement de M\u00e9decine Nucl\u00e9aire, Institut Gustave-Roussy, Villejuif France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112567294","display_name":"S. Sil\u00e8s","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162909","display_name":"H\u00f4pital de la Timone","ror":"https://ror.org/05jrr4320","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210162909"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Siles","raw_affiliation_strings":["De\u0301partement de Me\u0301decine Nucle\u0301aire, Hopital d'Enfant de la Timone, Marseille, France","D\u00e9partement de M\u00e9decine Nucl\u00e9aire, Hopital d'Enfant de la Timone, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"De\u0301partement de Me\u0301decine Nucle\u0301aire, Hopital d'Enfant de la Timone, Marseille, France","institution_ids":["https://openalex.org/I4210162909"]},{"raw_affiliation_string":"D\u00e9partement de M\u00e9decine Nucl\u00e9aire, Hopital d'Enfant de la Timone, Marseille, France","institution_ids":["https://openalex.org/I4210162909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042416572","display_name":"Michel Wioland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086685","display_name":"H\u00f4pital Armand-Trousseau","ror":"https://ror.org/00yfbr841","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210086685","https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Wioland","raw_affiliation_strings":["Antenne de Me\u0301decine Nucle\u0301aire, Hopital d'Enfants Armand Trousseau, Paris, France","Antenne de M\u00e9decine Nucl\u00e9aire, Hopital d'Enfants Armand Trousseau, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antenne de Me\u0301decine Nucle\u0301aire, Hopital d'Enfants Armand Trousseau, Paris, France","institution_ids":["https://openalex.org/I4210086685"]},{"raw_affiliation_string":"Antenne de M\u00e9decine Nucl\u00e9aire, Hopital d'Enfants Armand Trousseau, Paris, France","institution_ids":["https://openalex.org/I4210086685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103345321","display_name":"Fr\u00e9d\u00e9r\u00edc Gomez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Gomez","raw_affiliation_strings":["De\u0301partement de Pe\u0301datrie, Me\u0301decine Nucle\u0301aire and Biostatistiques, Centre Le\u0301on Be\u0301rard, Lyon, France","D\u00e9partement de P\u00e9datrie, M\u00e9decine Nucl\u00e9aire and Biostatistiques, Centre L\u00e9on B\u00e9rard, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"De\u0301partement de Pe\u0301datrie, Me\u0301decine Nucle\u0301aire and Biostatistiques, Centre Le\u0301on Be\u0301rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"D\u00e9partement de P\u00e9datrie, M\u00e9decine Nucl\u00e9aire and Biostatistiques, Centre L\u00e9on B\u00e9rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the SFOP Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"for the SFOP Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5033870647"],"corresponding_institution_ids":["https://openalex.org/I4210105738"],"apc_list":null,"apc_paid":null,"fwci":0.6512,"has_fulltext":false,"cited_by_count":42,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.68255781,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"34","issue":"4","first_page":"237","last_page":"241"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-neuroblastoma","display_name":"metastatic neuroblastoma","score":0.890999972820282},{"id":"https://openalex.org/keywords/metaiodobenzylguanidine","display_name":"metaiodobenzylguanidine","score":0.9340000152587891},{"id":"https://openalex.org/keywords/mibg-scintigraphy","display_name":"MIBG scintigraphy","score":0.9919999837875366},{"id":"https://openalex.org/keywords/observer-agreement","display_name":"observer agreement","score":0.5210000276565552},{"id":"https://openalex.org/keywords/induction-chemotherapy-response","display_name":"induction chemotherapy response","score":0.7860000133514404},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9490000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8791121244430542},{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.6152011752128601},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.442902147769928},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3545701205730438},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005544","descriptor_name":"Forecasting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011877","descriptor_name":"Radionuclide Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013223","descriptor_name":"Statistics as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015337","descriptor_name":"Multicenter Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015588","descriptor_name":"Observer Variation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019797","descriptor_name":"3-Iodobenzylguanidine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/(sici)1096-911x(200004)34:4<237::aid-mpo1>3.0.co;2-j","doi":"https://doi.org/10.1002/(sici)1096-911x(200004)34:4<237::aid-mpo1>3.0.co;2-j","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1096-911x(200004)34:4<237::aid-mpo1>3.0.co;2-j","pdf_url":null,"source":{"id":"https://openalex.org/S179546387","display_name":"Medical and Pediatric Oncology","issn_l":"0098-1532","issn":["0098-1532","1096-911X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320571","host_organization_name":"Alan R. Liss, Inc.","host_organization_lineage":["https://openalex.org/P4310320571"],"host_organization_lineage_names":["Alan R. Liss, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical and Pediatric Oncology","raw_type":"journal-article"},{"id":"pmid:10742058","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10742058","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical and pediatric oncology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1840673949","https://openalex.org/W1845402765","https://openalex.org/W1864337426","https://openalex.org/W1981028064","https://openalex.org/W2000383339","https://openalex.org/W2016760673","https://openalex.org/W2052566889","https://openalex.org/W2053309800","https://openalex.org/W2070550035","https://openalex.org/W2089332564","https://openalex.org/W2096398040","https://openalex.org/W2147599215","https://openalex.org/W2245308948","https://openalex.org/W2266772060","https://openalex.org/W2413633611","https://openalex.org/W2425753754","https://openalex.org/W2979123501"],"related_works":["https://openalex.org/W2147599215","https://openalex.org/W2070550035","https://openalex.org/W2168240861","https://openalex.org/W2121955260","https://openalex.org/W7009460422","https://openalex.org/W2314315503","https://openalex.org/W2003397733","https://openalex.org/W2118018889","https://openalex.org/W2155333681","https://openalex.org/W2155254558"],"abstract_inverted_index":{"BACKGROUND:":[0],"In":[1],"children":[2],"over":[3],"1":[4],"year":[5],"of":[6,12,20,25,35,65,147,167,187],"age":[7],"with":[8,170,190],"metastatic":[9],"neuroblastoma,":[10],"clearance":[11],"metaiodobenzylguanidine":[13],"(MIBG)":[14],"skeletal":[15],"uptake":[16],"after":[17,107],"four":[18,79],"courses":[19,109],"induction":[21,57,230],"chemotherapy":[22],"is":[23,33,203],"one":[24],"the":[26,98,104,111,117,134,138,160],"most":[27],"powerful":[28],"prognostic":[29],"factors.":[30],"How":[31],"subjective":[32],"quantification":[34],"MIBG":[36,41,66,225],"uptake,":[37],"and":[38,45,76,97,205,215],"can":[39],"earlier":[40],"scintigraphy":[42],"separate":[43],"good":[44,175,197],"bad":[46],"responders?":[47],"PROCEDURE:":[48],"The":[49,93,154,177],"data":[50],"from":[51],"47":[52],"patients":[53,169,189],"who":[54,124],"received":[55],"uniform":[56],"therapy":[58,231],"were":[59,82,114,122,174,196],"reviewed.":[60],"A":[61],"novel":[62],"scoring":[63,201],"system":[64,202],"update":[67],"intensity":[68],"was":[69,141],"proposed.":[70],"Initial,":[71],"intermediate":[72,224],"(after":[73,78],"two":[74,108,132],"courses),":[75],"final":[77,118,128,161,221],"courses)":[80],"intensities":[81],"scored":[83,125],"(0":[84],"to":[85,116,143,182,219],"21":[86],"points)":[87],"independently":[88],"by":[89,102,110],"six":[90,186],"different":[91],"observers.":[92],"initial":[94,112,155,172,214],"global":[95,105,139],"score":[96,100,106,140,156,162,179,193],"relative":[99,178,192,216],"(calculated":[101],"dividing":[103],"score)":[113],"compared":[115],"score.":[119],"Good":[120],"responders":[121],"those":[123],"0":[126],"at":[127],"MIBG.":[129],"RESULTS:":[130],"Between":[131],"observers,":[133],"correlation":[135],"coefficient":[136],"for":[137],"superior":[142],"0.80,":[144],"in":[145,209],"nine":[146,166],"ten":[148,188],"comparisons":[149],"established":[150],"between":[151],"observers":[152],"1-5.":[153],"did":[157],"not":[158],"predict":[159,183,220],"insofar":[163],"as":[164],"only":[165,185],"fourteen":[168],"low":[171],"scores":[173,217],"responders.":[176,198],"also":[180],"failed":[181,218],"outcome;":[184],"favorable":[191],"(i.e.,":[194],"<20%),":[195],"CONCLUSIONS:":[199],"This":[200],"reliable":[204],"may":[206,226],"be":[207,227],"used":[208],"multicentric":[210],"trials.":[211],"However,":[212],"both":[213],"outcome.":[222],"Thus,":[223],"omitted":[228],"during":[229],"assessment.":[232]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000279511","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
